- Parties: The plaintiffs were Boehringer Ingelheim(Canada) Ltd. and Boehringer Ingelheim International GmbH. The defendant was Laboratoire Riva Inc. 

- Subject Matter: This action involved the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133. This case is ongoing. 

- Date: The hearing was set on Feb. 10, 2025. 

- Venue: This was a federal case before the Federal Court. 

- Amount: No financial award was specified.